Since March 2022, Canadian couple Edith Lemay and Sebastian Pelletier and their four children have been on the move, taking in sights and sounds as they tour the world. From the dunes in Namibia and valleys in Kilimanjaro to dancing with the Maasai tribals in Tanzania, hot-air ballooning in Turkey and dressing up as a nomadic reindeer herder in Mongolia, it has not been merely a travel for leisure but one with a purpose. For Lemay and Pelletier, this journey is all about creating visual memories for their children. Memories-snapshots of our lived experience-are essential as they help connect our past with our present and prepare us for the future. And, Lemay and Pelletier are hoping these visual memories, carefully curated by them, may come handy for the children when they face the dark days ahead.
"Three of my children have retinitis pigmentosa (RP), a genetic disease without any cure as of now," Lemay told THE WEEK over a Zoom call from Thailand. "Our eldest kid, Mia, is 11 now. Then there is Leo, who is nine, Colin, who is seven, and Laurent, who is five. Leo is the only one who is not affected by RP."
Retinitis pigmentosa is a group of rare eye diseases that affect the retina. It makes cells in the retina break down slowly over time, causing vision loss. It is a disease that people are born with. Symptoms usually start in childhood, and most people eventually lose most of their vision. The retinal cells called rods and cones die in patients with RP because of a mutation in one of their genes. In a majority of cases, rods mainly located in the outer regions of the retina and responsible for peripheral and night vision-die down first. When more centrally located conduits also get affected, the patient with RP would face loss of colour perception and central (reading) vision, too.
This story is from the February 05, 2023 edition of THE WEEK India.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the February 05, 2023 edition of THE WEEK India.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Hat-Trick Or Has-Beens?
India look to win their third straight Test series in Australia, but ageing superstars and recent humiliation at home have cast a shadow on their hopes
Constipation Can Put Your Heart At Risk
PEOPLE WITH CONSTIPATION have an increased risk of major cardiac events, including heart attack, stroke and heart failure, especially if they also have high blood pressure, finds an international study published in the American Journal of Physiology-Heart and Circulatory Physiology.
Too Much Sitting Can Accelerate Ageing
SITTING FOR EXTENDED PERIODS can harm the heart and accelerate ageing, even if you are young and get the minimum recommended amount of daily exercise, according to a US study published in the journal PLOS One.
Efficiency and innovation
As health care evolves, professionals must employ innovative methods to refine their skills
Level up
Only 30 per cent of needy patients are able to undergo transplant in India; we need more dedicated transplant centres
HOPE STEMS FROM A CELL
While stem cell therapies have shown success in treating blood disorders, orthopaedic ailments, autoimmune diseases and eye issues, there is hope that they can one day treat patients with heart disease, blindness, Parkinson's, HIV, diabetes and spinal cord injuries
Mind matters
Your mindset can limit or expand your physical ability
Cutting edge
Would you go under the knife if a robot was the one holding it? Or would you say, \"No way, I need a human touch\"? You might have to decide soon because a robot that can imitate skilled human surgeons is already here.
The smallest cut
Minimally invasive surgeries have a bright future, with virtual reality and 3D procedures offering greater precision and AI on the horizon
Signalling a revolution
Canadian scientist and entrepreneur Sachdev Sidhu is focused on bringing cutting-edge antibody engineering to his country of origin